Molecular subtypes and clinicopathological features of breastcancer
https://doi.org/10.19106/JMedScie004501201306
. Irianiwati
(1*)
(1) Department of Anatomical Pathology, Faculty of Medicine, Universitas Gadjah Mada/Dr. Sardjito General Hospital, Yogyakarta
(*) Corresponding Author
Abstract
Breast cancer is a heterogeneous disease with regard to morphological spectrum, clinical presentation and response to therapy. Based on immunohistochemistry detection of estrogen receptor, progesterone receptor, Her-2 status, proliferation rate and clusters of basal gene expression, breast cancers can be classified into luminal A, luminal B, basal-like/triple negative, and Her-2 positive. It was suggested that there was a close relationship between molecular subtypes and clinicopathological features of breast cancer, as they are very important to predict prognosis and therapeutic implications.
Keywords
molecular subtypes - breast cancer- clinicopathological features -heterogeneity –theraputicimplications
DOI:
https://doi.org/10.19106/JMedScie004501201306
Article Metrics
Abstract views : 937
|
views : 1526
Copyright (c) 1970 . Irianiwati
This work is licensed under a
Creative Commons Attribution-NonCommercial 4.0 International License .
<div class="statcounter"><a title="real time web analytics" href="https://statcounter.com/" target="_blank"><img class="statcounter" src="https://c.statcounter.com/10697571/0/23d82b78/0/" alt="real time web analytics"></a></div> <div class="statcounter"><a title="shopify visitor statistics" href="http://statcounter.com/shopify/" target="_blank"><img class="statcounter" src="http://c.statcounter.com/10697571/0/23d82b78/0/" alt="shopify visitor statistics"></a></div>
View My Stats
Journal of the Medical Sciences (Berkala Ilmu Kedokteran ) by Universitas Gadjah Mada is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License . Based on a work at http://jurnal.ugm.ac.id/bik/ .